Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
Krentz AJ, Morrow L, Petersson M, Norjavaara E, Hompesch M.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information, such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.
Analytics cookies used:
Google Tag Manager
Please enable Strictly Necessary Cookies first so that we can save your preferences!